Form D Explorer

Form D — Newleos Therapeutics, Inc.

0002057800-25-000001 · filed 2025-02-24

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $93,449,993
Total sold: $93,449,993
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Newleos Therapeutics, Inc.
CIK: 2057800
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2024
Address: C/O NEWLEOS THERAPEUTICS, INC.
BOSTON, MA 02199
Phone: (617) 648-9100

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

David Donabedian · Executive Officer

Boston, MA Find on LinkedIn ↗
John McCabe · Executive Officer

Boston, MA Find on LinkedIn ↗
Ming Cheah · Director

Boston, MA Find on LinkedIn ↗
Christoph Westphal · Director

Boston, MA Find on LinkedIn ↗
Raymond Camahort · Director

Boston, MA Find on LinkedIn ↗
Robert Hadfield · Executive Officer

Boston, MA Find on LinkedIn ↗

View original on SEC EDGAR.